MoonLake Immunotherapeutics (MLTX) Times Interest Earned (2021 - 2026)
MoonLake Immunotherapeutics' (MLTX) quarterly Times Interest Earned came in at -$30.45 in Q1 2026, up 76.41% year-on-year from -$17.26 in Q1 2025, and down 111.25% quarter-over-quarter from $270.61 in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Times Interest Earned (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Times Interest Earned history runs 6 years deep, the most recent figure standing at -$30.45 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 76.41% year-over-year to -$30.45 in Q1 2026; TTM through Mar 2026 was -$47.53, a 67.67% increase from a year earlier, with the FY2025 full-year figure at -$33.78, down 488.57% from the prior year.
- Times Interest Earned declined to -$30.45 in Q1 2026 per MLTX's latest filing, from $270.61 in the prior quarter.
- Across five years, Times Interest Earned topped out at $270.61 in Q4 2025 and bottomed at -$24265.3 in Q1 2022.
- The 5-year median for Times Interest Earned is -$86.9 (2023), against an average of -$1576.6.
- Across the five-year window, Times Interest Earned slumped 5296.03% in 2022 and soared 240.06% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$494.61 in 2022, then jumped by 82.43% to -$86.9 in 2023, then sank by 122.34% to -$193.21 in 2024, then surged by 240.06% to $270.61 in 2025, then slumped by 111.25% to -$30.45 in 2026.
- Per Business Quant, the three latest MLTX Times Interest Earned figures stand at -$30.45 (Q1 2026), $270.61 (Q4 2025), and -$22.34 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | MoonLake Immunotherapeutics | 1.35 Bn | 991.29 Mn | - | -30.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.45 |
| Dec 31, 2025 | 270.61 |
| Sep 30, 2025 | -22.34 |
| Jun 30, 2025 | -2.37 |
| Mar 31, 2025 | -129.04 |
| Dec 31, 2024 | -193.21 |
| Sep 30, 2024 | -12.05 |
| Jun 30, 2024 | -147.67 |
| Mar 31, 2024 | -54.45 |
| Dec 31, 2023 | -86.90 |
| Sep 30, 2023 | -76.24 |
| Jun 30, 2023 | -62.08 |
| Mar 31, 2023 | -333.07 |
| Dec 31, 2022 | -494.61 |
| Sep 30, 2022 | -908.23 |
| Jun 30, 2022 | -254.06 |
| Mar 31, 2022 | -24,265.32 |
| Dec 31, 2021 | -9.17 |